Table 1 Summary of the included studies
Author | year | Journal | Modality | TP | FP | FN | TN | Sensitivity (95%CI) | Specificity (95% CI) | QUADAS |
|---|---|---|---|---|---|---|---|---|---|---|
Stevens MH | 1985 | Arch Otolaryngol Head Neck Surg | CT | 5 | 1 | 1 | 9 | 83%(54-100%) | 90%(71-100%) | 9 |
Maremonti P | 1997 | J Craniomaxillofac Surg | CT | 6 | 0 | 6 | 12 | 50%(22-78%) | 100% | 7 |
Righi PD | 1997 | Head Neck | CT | 6 | 0 | 4 | 23 | 60%(30-90%) | 100% | 7 |
Byers RM | 1998 | Head Neck | CT | 2 | 2 | 9 | 12 | 18%(0-41%) | 86%(67-100%) | 5 |
Myers LL | 1998 | Laryngoscope | CT | 4 | 1 | 3 | 9 | 57%(21-94%) | 90%(71-100%) | 10 |
Takes RP | 1998 | Int J Radiat Oncol Biol Phys | CT | 14 | 3 | 12 | 35 | 54%(35-73%) | 92%(84-100%) | 11 |
Akoglu E | 2005 | J Otolaryngol | CT | 2 | 1 | 1 | 10 | 67%(13-100%) | 91%(74-100%) | 10 |
Wilson GR | 1994 | Br J Plast Surg | MRI | 11 | 14 | 0 | 13 | 100% | 48%(29-67%) | 11 |
Braams JW | 1995 | J Nucl Med | MRI | 3 | 2 | 2 | 5 | 60%(17-100%) | 71%(38-100%) | 7 |
Maremonti P | 1997 | J Craniomaxillofac Surg | MRI | 4 | 4 | 8 | 8 | 33%(7-60%) | 67%(40-93%) | 7 |
Yucel T | 1997 | Acta Radiol | MRI | 4 | 1 | 1 | 12 | 80%(45%-100%) | 92%(78-100%) | 10 |
Akoglu E | 2005 | J Otolaryngol | MRI | 2 | 1 | 1 | 10 | 67%(13-100%) | 91%(74-100%) | 10 |
Thomsen JB | 2005 | Acta Radiol | MRI | 5 | 4 | 9 | 52 | 36%(11-61%) | 93%(86-100%) | 7 |
Braams JW | 1995 | J Nucl Med | PET | 5 | 2 | 0 | 5 | 100% | 71%(38-100%) | 7 |
Myers LL | 1998 | J Otolaryngol | PET | 7 | 0 | 0 | 4 | 100% | 100% | 10 |
Myers LL | 1998 | Laryngoscope | PET | 7 | 0 | 2 | 15 | 78%(51-100%) | 100% | 10 |
Kau RJ | 2002 | Arch Otolaryngol Head Neck Surg | PET | 1 | 1 | 4 | 6 | 20%(0-55%) | 86%(60-100%) | 13 |
Brouwer J | 2004 | Eur Arch Otorhinolaryngol | PET | 2 | 1 | 1 | 11 | 67%(13-100%) | 92%(76-100%) | 9 |
Akoglu E | 2005 | J Otolaryngol | PET | 2 | 1 | 1 | 10 | 67%(13-100%) | 91%(74-100%) | 10 |
Schoder H | 2006 | J Nucl Med | PET | 6 | 4 | 3 | 23 | 67%(36-98%) | 85%(72-99%) | 10 |
Wensing BM | 2006 | Laryngoscope | PET | 3 | 4 | 5 | 16 | 38%(4-71%) | 80%(63-98%) | 11 |
Iyer NG | 2010 | Head Neck | PET | 15 | 4 | 14 | 113 | 52%(34-70%) | 97%(93%-100%) | 12 |
Liao CT | 2010 | J Nucl Med | PET | 26 | 66 | 33 | 143 | 55%(31-57%) | 68%(62-75%) | 13 |
Richard C | 2010 | Arch Otolaryngol Head Neck Surg | PET | 7 | 5 | 1 | 8 | 88%(65-100%) | 62%(35-88%) | 11 |
van den Brekel MW | 1993 | Eur Arch Otorhinolaryngol | US | 21 | 13 | 15 | 39 | 58%(42-74%) | 75%(63-87%) | 9 |
Maremonti P | 1997 | J Craniomaxillofac Surg | US | 8 | 1 | 4 | 11 | 67%(40-93%) | 92%(76-100%) | 7 |
Righi PD | 1997 | Head Neck | US | 6 | 5 | 4 | 18 | 60%(30-90%) | 78%(61-95%) | 7 |
Byers RM | 1998 | Head Neck | US | 3 | 4 | 8 | 10 | 27%(1-54%) | 71%(48-95%) | 5 |
Takes RP | 1998 | Int J Radiat Oncol Biol Phys | US | 18 | 11 | 8 | 27 | 69%(52-87%) | 71%(57-86%) | 11 |
Hodder SC | 2000 | Br J Oral Maxillofac Surg | US | 9 | 4 | 3 | 17 | 75%(51-100%) | 81%(64-98%) | 7 |
Akoglu E | 2005 | J Otolaryngol | US | 3 | 4 | 0 | 7 | 100% | 64%(35-92%) | 10 |
Thomsen JB | 2005 | Acta Radiol | US | 13 | 10 | 2 | 55 | 87%(70-100%) | 85%(76-93%) | 7 |